- 2026-03-18 15:17RXFP3/4 agonist 1 2351104-40-8
- 2026-03-18 15:17RXFP2agonist 1 2971704-58-0
- 2026-03-18 15:17RXFP2 agonist 2 2971704-85-3
- 2026-03-18 15:16RXFP1 receptor agonist-8 2941271-76-5
- 2026-03-18 15:16RXFP1 receptor agonist-7 2941484-13-3
- 2026-03-18 15:16RXFP1 receptor agonist-6 2941346-85-4
- 2026-03-18 15:16RXFP1 receptor agonist-5 2941385-36-8
- 2026-03-18 15:16RXFP1 receptor agonist-4 2941376-76-5
- 2026-03-18 15:16RXFP1 receptor agonist-3 2924767-53-1
- 2026-03-18 15:16RXFP1 receptor agonist-2 2924460-54-6
- 2026-03-18 15:16RXFP1 receptor agonist-1 2924619-64-5
- 2026-03-18 15:16rTRD01 1332175-56-0
- 2026-03-18 15:16RS5517 2227017-46-9
- 2026-03-18 15:16RPE65-IN-1 1141779-07-8
- 2026-03-18 15:16Rocbrutinib 2485861-07-0
- 2026-03-18 15:15RNF114 ligand 1 900137-36-2
- 2026-03-18 15:15RNA polymerase-IN-2 2447106-79-6
- 2026-03-18 15:15RNA polymerase-IN-1 2447106-74-1
- 2026-03-18 15:15RIOK2-IN-2 2648987-17-9
- 2026-03-18 15:15RIOK2-IN-1 1088216-72-1
